Gene · 3868
Papers3,220
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,220
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Narrowband-Ultraviolet B Phototherapy for Psoriasis Treatment in Skin of Color: A Systematic Review and Meta-Analysis. | Photodermatol Photoimmunol Photomed | 2025 | 40908513 | PubTator, text mining | PubMed |
| SOX2 drives esophageal squamous carcinoma by reprogramming lipid metabolism and histone acetylation landscape. | Nat Commun | 2025 | 40897722 | PubTator, text mining | PubMed |
| Exploring the Role of GLP-1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review. | Wound Repair Regen | 2025 | 40888511 | PubTator, text mining | PubMed |
| Re-Epithelialisation in a Yorkshire Pig Full-Thickness Excisional Wound Model Is Associated With Keratinocyte Activation, Oxidative Stress, and Biomacromolecule Oxidation. | Wound Repair Regen | 2025 | 40880422 | PubTator, text mining | PubMed |
| 3D collagen high-throughput screen identifies drugs that induce epithelial polarity and enhance chemotherapy response in colorectal cancer. | Commun Biol | 2025 | 40847193 | PubTator, text mining | PubMed |
| CyTOF profiling of bone marrow immune dynamics across myeloma stages. | Oncoimmunology | 2025 | 40820826 | PubTator, text mining | PubMed |
| Integrative bulk RNA analysis unveils immune evasion mechanisms and predictive biomarkers of osimertinib resistance in non-small cell lung cancer. | Discov Oncol | 2025 | 40796706 | PubTator, text mining | PubMed |
| Knockdown of S100A9 inhibits pyroptosis and promotes PPAR signaling pathway in atopic dermatitis. | Biochem Biophys Res Commun | 2025 | 40773921 | PubTator, text mining | PubMed |
| Preconditioning of sediment failure by astronomically paced weak-layer deposition. | Nat Commun | 2025 | 40770177 | PubTator, text mining | PubMed |
| Combining mucosal microbiome and host multi-omics data shows prognostic potential in paediatric ulcerative colitis. | Nat Commun | 2025 | 40759968 | PubTator, text mining | PubMed |
| Pathogenic morphological signatures of perturbations in mitochondrial-related genes revealed by pooled imaging assay. | Npj Imaging | 2025 | 40751083 | PubTator, text mining | PubMed |
| Large-scale copy number variant analysis in genes linked to Parkinson´s disease. | NPJ Parkinsons Dis | 2025 | 40750593 | PubTator, text mining | PubMed |
| Revealing the impact of Pseudomonas aeruginosa quorum sensing molecule 2'-aminoacetophenone on the human bronchial-airway epithelium and pulmonary endothelium using a human airway-on-a-chip. | Front Immunol | 2025 | 40735328 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of Gastric Cancer Reveals Key Biomarkers and Pathways via Bioinformatic Analysis. | Genes (Basel) | 2025 | 40725485 | PubTator, text mining | PubMed |
| Determination of high-grade serous ovarian cancer stem cell-based subtypes and prognostic model and identification of highly expressed VSIG4 and STAB1 in macrophages. | J Ovarian Res | 2025 | 40702505 | PubTator, text mining | PubMed |
| Autoantibody reactome analysis reveals diagnostic biomarkers and molecular classification for relapsing polychondritis. | Ann Rheum Dis | 2025 | 40634188 | PubTator, text mining | PubMed |
| Machine learning-based prediction models for atopic dermatitis diagnosis and evaluation. | Fundam Res | 2025 | 40528978 | PubTator, text mining | PubMed |
| A novel efferocytosis-related gene signature for predicting prognosis and therapeutic response in bladder cancer. | Sci Rep | 2025 | 40481075 | PubTator, text mining | PubMed |
| Berberine in the treatment of radiation-induced skin injury: insights from proteomics and network pharmacology. | Front Pharmacol | 2025 | 40421220 | PubTator, text mining | PubMed |
| Identification and validation of shared biomarkers and drug repurposing in psoriasis and Crohn's disease: integrating bioinformatics, machine learning, and experimental approaches. | Front Immunol | 2025 | 40406126 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3868/papers?page=5